apceth-301

N/A

Report date: 2025/03/14 18:10:43

Base Information

Drug Nameapceth-301
Drug Alias Namegenetically-modified allogeneic mesenchymal stem cell therapy (apceth)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesApceth Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesApceth Gmbh & Co Kg
Inactive CompaniesN/A
Active IndicationsSolid tumoursGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A